Clinical Trials Browser

Phase 1/2 × Unknown × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Clear all

Leukemia, Myeloid, Acute, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03613428 2018-08-03

Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

Phase 1/2 Unknown

12 enrolled

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02742727 2016-12-06

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Phase 1/2 Unknown

10 enrolled

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT00363090 2013-09-20

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Phase 1/2 Unknown

84 enrolled

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma